Belite Bio (BLTE) Treasury Shares (2025)
Belite Bio (BLTE) recorded quarterly Treasury Shares of $155751.0 in Q4 2025.
Belite Bio (BLTE) Treasury Shares (2025) Analysis & Trends
Belite Bio's Treasury Shares history runs 1 years deep, the most recent figure standing at $155751.0 for Q4 2025.
- In Q4 2025, Treasury Shares changed N/A year-over-year to $155751.0; the TTM figure through Dec 2025 stood at $155751.0 (changed N/A YoY), while the FY2025 annual figure was $155751.0, changed N/A from the prior year.
- Treasury Shares was $155751.0 for Q4 2025 at Belite Bio.
- In the past five years, Treasury Shares ranged from a high of $155751.0 in Q4 2025 to a low of $155751.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.59 Bn | 54.83 Bn | 3.31 Bn | 34.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 155,751.00 |
| Dec 31, 2025 | 155,751.00 |